The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Functional biomarkers of homologous repair (HR) deficiency to guide novel DNA damage response targeted therapy in clear cell renal cell carcinoma (ccRCC).
 
Patrick Glen Pilie
No Relationships to Disclose
 
Christine B Peterson
No Relationships to Disclose
 
Yang Peng
No Relationships to Disclose
 
Lijun Zhou
No Relationships to Disclose
 
Timothy Anthony Yap
Honoraria - AstraZeneca
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Atrin Pharmaceuticals; Clovis Oncology; EMD Serono; Ignyta; Janssen; Pfizer; Tesaro
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca; Clearbridge Biomedics; Pfizer; Roche; Vertex
Patents, Royalties, Other Intellectual Property - Employee of The Institute of Cancer Research, which has a financial interest in the discovery and development of anticancer drugs (Inst)
Travel, Accommodations, Expenses - Vertex
 
Guang Peng
No Relationships to Disclose
 
Eric Jonasch
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Exelixis; Novartis; Peloton Therapeutics; Pfizer
Travel, Accommodations, Expenses - Pfizer